Stifel analyst Patrick Ho downgrades Kornit Digital (NASDAQ:KRNT) from Buy to Hold and lowers the price target from $100 to $50.
Analysts Question Commercial Viability of Marinus’ IV Ganaxolone After Interim Analysis Miss
Marinus Pharmaceuticals' phase 3 RAISE trial on IV ganaxolone for refractory status epilepticus fails interim analysis. Future development to be assessed post final results review.